Regeneron (REGN) Tops Q1 EPS by 47c

Regeneron (NASDAQ: REGN) reported Q1 EPS of $6.60, $0.47 better than the analyst estimate of $6.13. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.76 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group